Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Charney, A W; Ruderfer, D M; Stahl, E A; Moran, J L; Chambert, K; Belliveau, R A; Forty, L; Gordon-Smith, K; Di Florio, A; Lee, P H; Bromet, E J; Buckley, P F; Escamilla, M A; Fanous, A H; Fochtmann, L J; Lehrer, D S; Malaspina, D; Marder, S R; Morley, C P; Nicolini, H; Perkins, D O; Rakofsky, J J; Rapaport, M H; Medeiros, H; Sobell, J L; Green, E K; Backlund, L; Bergen, S E; Jur?us, A; Schalling, M ... view all 45 authors View less authors (2017)
Publisher: Nature Publishing Group
Journal: Translational Psychiatry
Languages: English
Types: Article
Subjects: RC0321, Original Article, BF, R1
We performed a genome-wide association study of 6447 bipolar disorder (BD) cases and 12 639 controls from the International\ud Cohort Collection for Bipolar Disorder (ICCBD). Meta-analysis was performed with prior results from the Psychiatric Genomics\ud Consortium Bipolar Disorder Working Group for a combined sample of 13 902 cases and 19 279 controls. We identified eight\ud genome-wide significant, associated regions, including a novel associated region on chromosome 10 (rs10884920; P = 3.28 × 10− 8)\ud that includes the brain-enriched cytoskeleton protein adducin 3 (ADD3), a non-coding RNA, and a neuropeptide-specific\ud aminopeptidase P (XPNPEP1). Our large sample size allowed us to test the heritability and genetic correlation of BD subtypes and\ud investigate their genetic overlap with schizophrenia and major depressive disorder. We found a significant difference in heritability\ud of the two most common forms of BD (BD I SNP-h2 = 0.35; BD II SNP-h2 = 0.25; P = 0.02). The genetic correlation between BD I and\ud BD II was 0.78, whereas the genetic correlation was 0.97 when BD cohorts containing both types were compared. In addition, we\ud demonstrated a significantly greater load of polygenic risk alleles for schizophrenia and BD in patients with BD I compared with\ud patients with BD II, and a greater load of schizophrenia risk alleles in patients with the bipolar type of schizoaffective disorder\ud compared with patients with either BD I or BD II. These results point to a partial difference in the genetic architecture of BD\ud subtypes as currently defined.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 Kraepelin E. Manic-Depressive Insanity and Paranoia. E. & S. Livingstone, Edinburgh, 1921.
    • 2 Leonhard K. Pathogenesis of manic-depressive disease. Der Nervenarzt 1957; 28: 271-272.
    • 3 Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry 1976; 11: 31-42.
    • 4 Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976; 133: 925-929.
    • 5 Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251.
    • 6 Ferrari AJ, Baxter AJ, Whiteford HA. A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J Affect Disord 2011; 134: 1-13.
    • 7 Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-151.
    • 8 Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2007; 64: 543-552.
    • 9 Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123C: 48-58.
    • 10 Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Am Med Assoc 1982; 39: 1157-1167.
    • 11 Heun R, Maier W. The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study. Acta Psychiatr Scand 1993; 87: 279-284.
    • 12 Vandeleur CL, Merikangas KR, Strippoli MPF, Castelao E, Preisig M. Specificity of psychosis, mania and major depression in a contemporary family study. Mol Psychiatry 2013; 19: 209-213.
    • 13 Merikangas KR, Cui L, Heaton L, Nakamura E, Roca C, Ding J et al. Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry 2014; 19: 214-219.
    • 14 Kasanin J. The acute schizoaffective psychoses. Am J Psychiatry 1933; 90: 97-126.
    • 15 Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortensen PB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry 2005; 62: 841-848.
    • 16 Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
    • 17 Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL et al. Schizophrenia Working Group of Psychiatric Genomics C Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry 2014; 19: 1017-1024.
    • 18 Bertelsen A. Gottesman II. Schizoaffective psychoses: genetical clues to classification. Am J Med Genet 1995; 60: 7-11.
    • 19 Cichon S, Mühleisen TW, Degenhardt FA, Mattheisen M, Miró X, Strohmaier J et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
    • 20 Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
    • 21 Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R et al. Genomewide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci USA 2009; 106: 7501-7506.
    • 22 Sklar P, Smoller JW, Fan J, Ferreira MAR. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008; 13: 558-569.
    • 23 Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W et al. Genomewide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009; 14: 755-763.
    • 24 Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
    • 25 Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 2009; 14: 487-491.
    • 26 Chen DT, Jiang X, Akula N, Shugart YY, Wendland JR, Steele CJ et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013; 18: 195-205.
    • 27 Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun 2014; 5: 3339.
    • 28 Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
    • 29 Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. International Schizophrenia Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
    • 30 Lee SH, Ripke S, Neale BM, Faraone S V, Purcell SM, Perlis RH et al. Genetic relationship between five psychiatric disorders estimated from genomewide SNPs. Nat Genet 2013; 45: 984-994.
    • 31 Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011; 88: 294-305.
    • 32 Lee SH, DeCandia TR, Ripke S, Yang J, Sullivan PF, Goddard ME et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet 2012; 44: 247-250.
    • 33 Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS et al. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 2010; 167: 1254-1263.
    • 34 Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-1379.
    • 35 Lee SH, Yang J, Goddard ME, Visscher PM, Wray NR. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 2012; 28: 2540-2542.
    • 36 Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
    • 37 Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA et al. UK IBD Genetics Consortium Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009; 41: 1330-1334.
    • 38 Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genomewide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012; 17: 880-886.
    • 39 Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder casecontrol sample. Mol Psychiatry 2013; 18: 1302-1307.
    • 40 Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593.
    • 41 Pato MT, Sobell JL, Medeiros H, Abbott C, Sklar BM, Buckley PF et al. The Genomic Psychiatry Cohort: Partners in Discovery. Am J Med Genet B Neuropsychiatr Genet. 2013; 4: 306-312.
    • 42 McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
    • 43 Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013; 10: 5-6.
    • 44 Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955-959.
    • 45 Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genomewide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
    • 46 Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium., Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497-511.
    • 47 Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55: 997-1004.
    • 48 Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76-82.
    • 49 Kruer MC, Jepperson T, Dutta S, Steiner RD, Cottenie E, Sanford L et al. Mutations in gamma adducin are associated with inherited cerebral palsy. Ann Neurol 2013; 74: 805-814.
    • 50 Harbeck HT, Mentlein R. Aminopeptidase P from rat brain. Purification and action on bioactive peptides. Eur J Biochem 1991; 198: 451-458.
    • 51 Xu K, Zhong G, Zhuang X. Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science 2013; 339: 452-456.
    • 52 O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011; 16: 286-292.
    • 53 Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpe S. Proline motifs in peptides and their biological processing. FASEB J 1995; 9: 736-744.
    • 54 Yoon SH, Bae YS, Mun MS, Park KY, Ye SK, Kim E et al. Developmental retardation, microcephaly, and peptiduria in mice without aminopeptidase P1. Biochem Biophys Res Commun 2012; 429: 204-209.
    • 55 Ioannidis JPA, Thomas G, Daly MJ. Validating, augmenting and refining genomewide association signals. Nat Rev Genet 2009; 10: 318-329.
    • 56 Parker G, Graham R, Hadzi-Pavlovic D, McCraw S, Hong M, Friend P. Differentiation of bipolar I and II disorders by examining for differences in severity of manic/ hypomanic symptoms and the presence or absence of psychosis during that phase. J Affect Disord 2013; 150: 941-947.
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

  • NIH | Neuroimaging genetics to st...
  • NIH | International Cohort Collec...
  • WT
  • NIH | Genomic Psychiatry Cohort
  • NIH | Mechanisms Linking Metastas...

Cite this article